[1]
|
陈显成, 甘卫东, 郭宏骞. Xp11.2易位/TFE3基因融合相关性肾癌: 一种需要更多认识的肾癌亚型[J]. 中华临床医师杂志(电子版), 2014, 8(21): 3749-3752.
|
[2]
|
Geller, J.I., Argani, P., Adeniran, A., et al. (2008) Translocation Renal Cell Carcinoma: Lack of Negative Impact Due to Lymph Node Spread. Cancer, 112, 1607-1616. https://doi.org/10.1002/cncr.23331
|
[3]
|
Dijkhuizen, T., van den Berg, E., Wilbrink, M., et al. (1995) Distinct Xp11.2 Breakpoints in Two Renal Cell Carcinomas Exhibiting X;autosome Translocations. Genes, Chromosomes and Cancer, 14, 43-50.
https://doi.org/10.1002/gcc.2870140108
|
[4]
|
Xu, L., Yang, R., Gan, W., et al. (2015) Xp11.2 Translocation Renal Cell Carcinomas in Young Adults. BMC Urology, 15, Article No. 57. https://doi.org/10.1186/s12894-015-0055-0
|
[5]
|
Yan, B.C., Mackinnon, A.C. and Al-Ahmadie, H.A. (2009) Recent Developments in the Pathology of Renal Tumors: Morphology and Molecular Characteristics of Select Entities. Archives of Pathology & Laboratory Medicine, 133, 1026-1032. https://doi.org/10.5858/133.7.1026
|
[6]
|
Argani, P., Aulmann, S., Karanjawala, Z., Fraser, R.B., Ladanyi, M. and Rodriguez, M.M. (2009) Melanotic Xp11 Translocation Renal Cancers: A Distinctive Neoplasm with Overlapping Features of PEComa, Carcinoma, and Melanoma. The American Journal of Surgical Pathology, 33, 609-619. https://doi.org/10.1097/PAS.0b013e31818fbdff
|
[7]
|
Camparo, P., Vasiliu, V., Molinie, V., et al. (2008) Renal Translocation Carcinomas: Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Analysis of 31 Cases with a Review of the Literature. The American Journal of Surgical Pathology, 32, 656-670. https://doi.org/10.1097/PAS.0b013e3181609914
|
[8]
|
饶秋, 周晓军. 青少年肾细胞癌分子遗传学研究进展[J]. 医学研究生学报, 2012, 25(9): 967-970.
|
[9]
|
Argani, P. and Ladanyi, M. (2005) Translocation Carcinomas of the Kidney. Clinics in Laboratory Medicine, 25, 363-378. https://doi.org/10.1016/j.cll.2005.01.008
|
[10]
|
Argani, P., Antonescu, C.R., Illei, P.B., Lui, M.Y., Timmons, C.F., Newbury, R., et al. (2001) Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma: A Distinctive Tumor Entity Previously Included among Renal Cell Carcinomas of Children and Adolescents. American Journal of Pathology, 159, 179-192.
https://doi.org/10.1016/S0002-9440(10)61684-7
|
[11]
|
Sidhar, S.K., Clark, J., Gill, S., et al. (1996) The t(X;1)(p11.2;q21.2) Translocation in Papillary Renal Cell Carcinoma Fuses a Novel Gene PRCC to the TFE3 Transcription Factor Gene. Human Molecular Genetics, 5, 1333-1338.
https://doi.org/10.1093/hmg/5.9.1333
|
[12]
|
Clark, J., Lu, Y.-J., Sidhar, S.K., et al. (1997) Fusion of Splicing Factor Genes PSF and NonO (p54nrb) to the TFE3 Gene in Papillary Renal Cell Carcinoma. Oncogene, 15, 2233-2239. https://doi.org/10.1038/sj.onc.1201394
|
[13]
|
Argani, P., Lui, M.Y., Couturier, J., Bouvier, R., Fournet, J.-C. and Ladanyi, M. (2003) A Novel CLTC-TFE3 Gene Fusion in Pediatric Renal Adenocarcinoma with t(X;17)(p11.2;q23). Oncogene, 22, 5374-5378.
https://doi.org/10.1038/sj.onc.1206686
|
[14]
|
Xia, Q.Y., Wang, Z., Chen, N., et al. (2017) Xp11.2 Translocation Renal Cell Carcinoma with NONO-TFE3 Gene Fusion: Morphology, Prognosis, and Potential Pitfall in Detecting TFE3 Gene Rearrangement. Modern Pathology, 30, 416-426. https://doi.org/10.1038/modpathol.2016.204
|
[15]
|
Cheng, X., Gan, W., Zhang, G., Li, X. and Guo, H. (2016) Clinical Characteristics of XP11.2 Translocation/TFE3 Gene Fusion Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies. BMC Urology, 16, Article No. 40. https://doi.org/10.1186/s12894-016-0154-6
|
[16]
|
Su, H.-H., Sung, M.-T., Chiang, P.-H., Cheng, Y.-T. and Chen, Y.-T. (2014) The Preliminary Experiences of Translocation Renal Cell Carcinoma and Literature Review. The Kaohsiung Journal of Medical Sciences, 30, 402-408.
https://doi.org/10.1016/j.kjms.2014.03.003
|
[17]
|
Wang, W., Ding, J., Li, Y., Wang, C., Zhou, L., Zhu, H. and Peng, W. (2014) Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion. PLoS One, 9, e99990. https://doi.org/10.1371/journal.pone.0099990
|
[18]
|
Ahluwalia, P., Nair, B. and Kumar, G. (2013) Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature. Case Reports in Urology, 2013, Article ID: 810590.
https://doi.org/10.1155/2013/810590
|
[19]
|
Wu, A., Kunju, L.P., Cheng, L. and Shah, R.B. (2008) Renal Cell Carcinoma in Children and Young Adults: Analysis of Clinicopathological, Immunohistochemical and Molecular Characteristics with an Emphasis on the Spectrum of Xp11.2 Translocation-Associated and Unusual Clear Cell Subtypes. Histopathology, 53, 533-544.
https://doi.org/10.1111/j.1365-2559.2008.03151.x
|
[20]
|
Altinok, G., Kattar, M.M., Mohamed, A., Poulik, J., Grignon, D. and Rabah, R. (2005) Pediatric Renal Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and Clinicopathologic Associations. Pediatric and Developmental Pathology, 8, 168-180. https://doi.org/10.1007/s10024-004-9106-3
|
[21]
|
Zou, H., Kang, X., Pang, L.J., Hu, W., Zhao, J., Qi, Y., et al. (2014) Xp11 Translocation Renal Cell Carcinoma in Adults: A Clinicopathological and Comparative Genomic Hybridization Study. International Journal of Clinical and Experimental Pathology, 7, 236-245.
|
[22]
|
Argani, P., Olgac, S., Tickoo, S.K., Goldfischer, M., Moch, H., Chan, D.Y., et al. (2007) Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum. The American Journal of Surgical Pathology, 31, 1149-1160. https://doi.org/10.1097/PAS.0b013e318031ffff
|
[23]
|
Malouf, G.G., Camparo, P., Molinié, V., Dedet, G., Oudard, S., Schleiermacher, G., et al. (2011) Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors. Journal of Urology, 185, 24-29. https://doi.org/10.1016/j.juro.2010.08.092
|
[24]
|
顿耀军, 于路平, 杜依青, 盛正祚, 王功伟, 徐涛, 黄晓波, 王晓峰. Xp11.2易位/TFE3基因融合相关性肾癌3例临床特征及文献回顾[J]. 现代泌尿外科杂志, 2015, 20(12): 863-866.
|
[25]
|
徐晓晨, 等. Xp11.2易位/TFE3基因融合相关性肾癌与肾透明细胞癌的螺旋CT诊断鉴别[J]. 现代泌尿外科杂志, 2012, 17(2): 122-124.
|
[26]
|
钟燕, 王海屹, 陈鑫, 郭爱桃, 马露, 王英伟, 叶慧义. Xp11.2/TFE3易位基因融合相关性肾癌的磁共振表现[J]. 中华医学杂志, 2016, 96(33): 2635-2639.
|
[27]
|
成瑶, 王勇, 张小勇, 常燕翔, 吴新生. Xp11.2易位/TFE3基因融合相关性肾癌的CT表现[J]. 医学影像学杂志, 2018, 28(5): 785-789.
|
[28]
|
饶秋, 周晓军, 吴波, 马恒辉, 周航波, 刘晓红, 陈洁宇. Xp11.2易位/TFE3基因融合相关性肾癌的病理特征与临床分析[J]. 中华病理学杂志, 2007, 36(4): 244-246.
|
[29]
|
Bruder, E., Passera, O., Harms, D., Leuschner, I., Ladanyi, M., Argani, P., et al. (2004) Morphologic and Molecular Characterization of Renal Cell Carcinoma in Children and Young Adults. The American Journal of Surgical Pathology, 28, 1117-1132. https://doi.org/10.1097/01.pas.0000131558.32412.40
|
[30]
|
Argani, P., Lal, P., Hutchinson, B., Lui, M.Y., Reuter, V. and Ladanyi, M. (2003) Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms with TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay. The American Journal of Surgical Pathology, 27, 750-761. https://doi.org/10.1097/00000478-200306000-00005
|
[31]
|
Wang, Z., Liu, N., Gan, W., Li, X., Zhang, G., Li, D. and Guo, H. (2017) Postoperative Recurrence of Adult Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion. Journal of International Medical Research, 45, 1287-1296. https://doi.org/10.1177/0300060517711358
|
[32]
|
Xu, L., Yang, R., Wang, W., Zhang, Y. and Gan, W. (2014) Laparoscopic Radiofrequency Ablation-Assisted Enucleation of Xp11.2 Translocation Renal Cell Carcinoma: A Case Report. Oncology Letters, 8, 1237-1239.
https://doi.org/10.3892/ol.2014.2267
|
[33]
|
Routh, J.C., Graham, D.A., Estrada, C.R. and Nelson, C.P. (2011) Contemporary Use of Nephron-Sparing Surgery for Children with Malignant Renal Tumors at Freestanding Children’s Hospitals. Urology, 78, 422-426.
https://doi.org/10.1016/j.urology.2010.12.048
|
[34]
|
Liu, C., Zhang, W. and Song, H. (2017) Nephron-Sparing Surgery in the Treatment of Pediatric Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions. Journal of Pediatric Surgery, 52, 1492-1495.
https://doi.org/10.1016/j.jpedsurg.2017.03.052
|
[35]
|
曹翔, 甘卫东. Xp11.2易位/TFE3基因融合相关性肾细胞癌的认知[J]. 中华腔镜泌尿外科杂志(电子版), 2014, 8(5): 374-377.
|
[36]
|
Cheng, X., He, J., Gan, W., et al. (2015) Pseudocapsule of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Clue for Tumor Enucleation? International Journal of Clinical & Experimental Pathology, 8, 5403-5410.
|
[37]
|
Argani, P., Laé, M., Ballard, E.T., Amin, M., Manivel, C., Reuter, B.H.V.E. and Ladanyi, M. (2006) Translocation Carcinomas of the Kidney after Chemotherapy in Childhood. Journal of Clinical Oncology, 24, 1529-1534.
https://doi.org/10.1200/JCO.2005.04.4693
|
[38]
|
Mansouri, D., Dimet, S., Couanet, D., Terrier-Lacombe, M.-J., et al. (2006) Renal Cell Carcinoma with an Xp11.2 Translocation in a 16-Year-Old Girl: A Case Report with Cytological Features. Diagnostic Cytopathology, 34, 757-760.
https://doi.org/10.1002/dc.20523
|
[39]
|
Malouf, G.G., Camparo, P., Oudard, S., et al. (2010) Targeted Agents in Metastatic Xp11 Translocation/TFE3 Gene Fusion Renal Cell Carcinoma (RCC): A Report from the Juvenile RCC Network. Annals of Oncology, 21, 1834-1838.
https://doi.org/10.1093/annonc/mdq029
|
[40]
|
Sudour-Bonnange, H., Leroy, X., Chauvet, M., Classe, M., Robin, P.M. and Leblond, P. (2014) Cutaneous Metastases during an Aggressive Course of Xp11.2 Translocation Renal Cell Carcinoma in a Teenager. Pediatric Blood & Cancer, 61, 1698-1700. https://doi.org/10.1002/pbc.25015
|
[41]
|
Agizamhan, S., Qu, F., Liu, N., Sun, J., Xu, W., Zhang, L., Guo, H. and Gan, W. (2018) Preoperative Neutrophil-to-Lymphocyte Ratio Predicts the Surgical Outcome of Xp11.2 Translocation/TFE3 Renal Cell Carcinoma Patients. BMC Urology, 18, Article No. 60. https://doi.org/10.1186/s12894-018-0374-z
|
[42]
|
Klaassen, Z., Tatem, A., Burnette, J.O., Donohoe, J.M. and Terris, M.K. (2012) Adult Xp11 Translocation Associated Renal Cell Carcinoma: Time to Recognize. Urology, 80, 965-968. https://doi.org/10.1016/j.urology.2012.07.051
|